Codagenix

Getty ImagesNaeblys

Pharma

Codagenix, Serum Institute take nasal COVID-19 vax into clinic

The partners are assessing the live attenuated candidate, COVI-VAC, in a 48-subject phase 1 clinical trial in the U.K.

Nick Paul Taylor Dec 21, 2020 10:03am

Syringe injection vaccine needle

Indian vaccine maker eyes $1B raise for COVID-19 effort: report

Aug 18, 2020 8:27am

Codagenix Founders

RSV vaccine player Codagenix snags $3M investment

Oct 12, 2017 12:15pm